Large Animal Teaching Hospital, Department of Large Animal Science, University of Copenhagen, Denmark.
Research Unit of Epidemiology and Risk Analysis applied to veterinary sciences (UREAR-ULg), Fundamental and Applied Research for Animal and Health (FARAH) Center, Faculty of Veterinary Medicine, University of Liege, Belgium.
J Equine Vet Sci. 2021 Jun;101:103451. doi: 10.1016/j.jevs.2021.103451. Epub 2021 Mar 26.
Non-steroidal anti-inflammatory drugs (NSAIDs) can cause right dorsal colitis, but longitudinal clinical studies are lacking. This study investigates whether NSAID treated horses develop right dorsal colonic pathology in a clinical setting. Non-gastrointestinal hospitalized horses treated with NSAIDs >4 days, and untreated hospital-owned teaching horses and non-gastrointestinal client-owned hospitalized horses were included. All horses were monitored over time with clinical examinations (focusing on presence of colic, depression, reduced appetite, unstructured feces), ultrasonographic intestinal wall measurements, fecal occult blood tests (semi-quantitative results), and blood analysis (total protein and albumin concentrations, white blood cell and neutrophil counts). Outcomes were recorded as "ultrasonographically thickened right dorsal colon (RDC) walls", "colitis" and "right dorsal colitis". Findings over time were compared to baseline values and to control horses. Seventeen NSAID treated horses and 5 controls were included. NSAID treated horses developed thickened RDC walls (4/9), and subclinical and mild colitis (9/11) and right dorsal colitis (4/10), whereas all control horses remained healthy. The first changes were identified on treatment day 2. RDC walls of treated horses were significantly thicker compared to their own baseline values and compared to control horses. In conclusion, presumptive colon pathology was identified with a high incidence, starting early in the course of treatment, but with low severity. Appropriate monitoring should be advised throughout NSAID treatment. Additional research for noninvasive diagnostic tests for colon pathology is required.
非甾体抗炎药(NSAIDs)可引起右背结肠炎症,但缺乏纵向临床研究。本研究旨在探讨在临床环境中,接受 NSAID 治疗的马匹是否会出现右背结肠病理变化。纳入了接受 NSAID 治疗超过 4 天的非胃肠道住院马、未接受治疗的医院自有教学马和非胃肠道的客户住院马。所有马匹均通过临床检查(重点关注是否存在腹痛、抑郁、食欲减退、无结构粪便)、超声肠壁测量、粪便潜血试验(半定量结果)和血液分析(总蛋白和白蛋白浓度、白细胞和中性粒细胞计数)进行定期监测。结果记录为“超声检查右背结肠(RDC)壁增厚”、“结肠炎”和“右背结肠炎”。随时间变化的发现与基线值和对照马进行了比较。纳入了 17 匹接受 NSAID 治疗的马和 5 匹对照马。接受 NSAID 治疗的马出现了 RDC 壁增厚(4/9)、亚临床和轻度结肠炎(9/11)和右背结肠炎(4/10),而所有对照马均保持健康。最早的变化发生在治疗的第 2 天。与自身基线值和对照马相比,治疗马的 RDC 壁明显增厚。结论,在治疗开始时就已经确定了较高发病率的疑似结肠病理变化,尽管严重程度较低。建议在 NSAID 治疗期间进行适当的监测。需要进一步研究非侵入性诊断结肠病理的测试。